Genomic and epidemiological report of the recombinant XJ lineage SARS-CoV-2 variant, detected in northern Finland, January 2022

Recombinant sequences of the SARS-CoV-2 Omicron variant were detected in surveillance samples collected in north-western Finland in January 2022. We detected 191 samples with an identical genome arrangement in weeks 3 to 11, indicating sustained community transmission. The recombinant lineage has a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindh, Erika, Smura, Teemu, Blomqvist, Soile, Liitsola, Kirsi, Vauhkonen, Hanna, Savolainen, Laura, Ikonen, Jaana, Ronkainen, Jukka, Taskila, Jyri, Taskila, Tea, Sakaranaho, Pertti, Savolainen-Kopra, Carita, Vapalahti, Olli, Ikonen, Niina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027151/
https://www.ncbi.nlm.nih.gov/pubmed/35451361
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.16.2200257
Descripción
Sumario:Recombinant sequences of the SARS-CoV-2 Omicron variant were detected in surveillance samples collected in north-western Finland in January 2022. We detected 191 samples with an identical genome arrangement in weeks 3 to 11, indicating sustained community transmission. The recombinant lineage has a 5’-end of BA.1, a recombination breakpoint between orf1a and orf1b (nucleotide position 13,296–15,240) and a 3’-end of BA.2 including the S gene. We describe the available genomic and epidemiological data about this currently circulating recombinant XJ lineage.

Ejemplares similares